Iron homeostasis during transfusional iron overload in β-thalassemia and sickle cell disease:: Changes in iron regulatory protein, hepcidin, and ferritin expression

被引:30
作者
Jenkins, Zandra A.
Hagar, Ward
Bowlus, Christopher L.
Johansson, Hans E.
Harmatz, Paul
Vichinsky, Elliott P.
Theil, Elizabeth C.
机构
[1] Univ Otago, Sch Med, Dept Pediat & Child Hlth, Dunedin, New Zealand
[2] Childrens Hosp, Oakland Res Inst, CeBIC, Oakland, CA 94609 USA
[3] Childrens Hosp, Oakland Res Inst, Dept Hematol Oncol, Oakland, CA 94609 USA
[4] Univ Calif Davis, Dept Internal Med, Sacramento, CA 95817 USA
[5] Biosearch Technol Inc, Novato, CA USA
[6] Childrens Hosp, Oakland Res Inst, Div Gastroenterol & Nutr, Oakland, CA 94609 USA
[7] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA
关键词
ferritin; hepcidin; hypertransfusion iron overload; iron regulatory proteins; sickle cell disease; beta-thalassemia;
D O I
10.1080/08880010701360700
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hypertransfusional (> 8 transfusions/year) iron in liver biopsies collected immediately after transfusions in beta- thalassemia and sickle cell disease correlated with increased expression ( RNA) for iron regulatory proteins 1 and 2 (3-, 9- to 11-fold) and hepcidin RNA: (5- to 8-fold) ( each p <. 01), while ferritin H and L RNA remained constant. A different H: L ferritin ratio in RNA ( 0.03) and protein ( 0.2-0.6) indicated disease-specific trends and suggests novel post-transcriptional effects. Increased iron regulatory proteins could stabilize the transferrin receptor mRNA and, thereby, iron uptake. Increased hepcidin, after correction of anemia by transfusion, likely reflects excess liver iron. Finally, the absence of a detectable change in ferritin mRNA indicates insufficient oxidative stress to significantly activate MARE/ARE promoters.
引用
收藏
页码:237 / 243
页数:7
相关论文
共 17 条
[1]  
Aoki CA, 2005, J CLIN GASTROENTEROL, V39, P71
[2]  
De Domenico I, 2006, HAEMATOLOGICA, V91, P1092
[3]  
FUNG EB, 2006, AM J HEMATOL 1108
[4]   Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease [J].
Fung, Ellen B. ;
Harmatz, Paul R. ;
Lee, Phillip D. K. ;
Milet, Meredith ;
Bellevue, Rita ;
Jeng, Michael R. ;
Kalinyak, Karen A. ;
Hudes, Mark ;
Bhatia, Suruchi ;
Vichinsky, Elliott P. .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (04) :574-582
[5]   CHARACTERIZATION AND EXPRESSION OF IRON REGULATORY PROTEIN-2 (IRP2) - PRESENCE OF MULTIPLE IRP2, TRANSCRIPTS REGULATED BY INTRACELLULAR IRON LEVELS [J].
GUO, B ;
BROWN, FM ;
PHILLIPS, JD ;
YU, Y ;
LEIBOLD, EA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (28) :16529-16535
[6]   Iron absorption by healthy women is not associated with either serum or urinary prohepcidin [J].
Hadley, Kevin B. ;
Johnson, LuAnn K. ;
Hunt, Janet R. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 84 (01) :150-155
[7]   Balancing acts: Molecular control of mammalian iron metabolism [J].
Hentze, MW ;
Muckenthaler, MU ;
Andrews, NC .
CELL, 2004, 117 (03) :285-297
[8]   DNA and mRNA elements with complementary responses to hemin, antioxidant inducers, and iron control ferritin-L expression [J].
Hintze, KJ ;
Theil, EC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (42) :15048-15052
[9]  
Kattamis A, 2006, HAEMATOLOGICA, V91, P809
[10]  
MASCOTTI DP, 1995, ANNU REV NUTR, V15, P239, DOI 10.1146/annurev.nu.15.070195.001323